Profil

QING Xiaobing

Main Referenced Co-authors
SCHWAMBORN, Jens Christian  (2)
Alexakos, Pavlos (1)
ARIAS, Jonathan  (1)
Asvos, Xenophon (1)
Cournia, Zoe (1)
Main Referenced Keywords
a-Synuclein (1); CRISPR/Cas9 (1); disease modeling (1); dopaminergic neurons (1); Genome editing (1);
Main Referenced Unit & Research Centers
Luxembourg Centre for Systems Biomedicine (LCSB): Developmental and Cellular Biology (Schwamborn Group) (1)
Main Referenced Disciplines
Genetics & genetic processes (2)
Life sciences: Multidisciplinary, general & others (1)

Publications (total 3)

The most downloaded
3 downloads
Arias, J., Jarazo, J., Qing, X., Walter, J., Gomez Giro, G., Nickels, S., Zaehres, H., Schoeler, H. R., & Schwamborn, J. C. (2017). FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling. Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026 https://hdl.handle.net/10993/32572

The most cited

65 citations (OpenCitations)

Arias, J., Jarazo, J., Qing, X., Walter, J., Gomez Giro, G., Nickels, S., Zaehres, H., Schoeler, H. R., & Schwamborn, J. C. (2017). FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling. Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026 https://hdl.handle.net/10993/32572

Qing, X. (2017). CRISPR/CAS9 AND PIGGYBAC MEDIATED LRRK2-G2019S IN VITRO PARKINSON’S DISEASE MODELING [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/31956

Spathis, A., Asvos, X., Ziavra, D., Karampelas, T., Topouzis, S., Cournia, Z., Qing, X., Alexakos, P., Smits, L., Dalla, C., Rideout, H., Schwamborn, J. C., Tamvakopoulos, C., Fokas, D., & Vassilatis, D. (2017). Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America. doi:10.1073/pnas.1616874114
Peer Reviewed verified by ORBi

Arias, J., Jarazo, J., Qing, X., Walter, J., Gomez Giro, G., Nickels, S., Zaehres, H., Schoeler, H. R., & Schwamborn, J. C. (2017). FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling. Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026
Peer Reviewed verified by ORBi

Contact ORBilu